Testosterone Replacement Therapy Can Correct, Prevent Anemia

Nearly 15% of older men with hypogonadism experience anemia. TRAVERSE is the first trial to report the effects of testosterone replacement therapy (TRT) on anemia incidence in hypogonal men.

Related Keywords

Canada , Boston , Massachusetts , United States , Toronto , Ontario , Shalender Bhasin , Shabbir Mh Alibhai , Abbvie Inc , Research Program In Men Health , University Health Network , Research Program , Hypogonadism Impact , Symptoms Questionnaire , Testosterone Replacement Therapy , Long Term Vascular Events , Efficacy Response , Hypogonadal Men ,